As of 2025-01-19, the EV/EBITDA ratio of Gilead Sciences Inc (GILD) is 9.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Gilead's latest enterprise value is 109,420.44 mil USD. Gilead's TTM EBITDA according to its financial statements is 11,161.00 mil USD. Dividing these 2 quantities gives us the above Gilead EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 16.1x | 14.6x |
| Forward P/E multiples | 12.3x - 14.6x | 13.2x |
| Fair Price | 91.57 - 148.05 | 116.36 |
| Upside | -0.3% - 61.2% | 26.7% |
| Date | EV/EBITDA |
| 2025-01-17 | 9.80 |
| 2025-01-16 | 9.78 |
| 2025-01-15 | 9.86 |
| 2025-01-14 | 9.71 |
| 2025-01-13 | 9.59 |
| 2025-01-10 | 9.58 |
| 2025-01-08 | 9.50 |
| 2025-01-07 | 9.67 |
| 2025-01-06 | 9.74 |
| 2025-01-03 | 9.76 |
| 2025-01-02 | 9.81 |
| 2024-12-31 | 9.86 |
| 2024-12-30 | 9.82 |
| 2024-12-27 | 10.06 |
| 2024-12-26 | 10.09 |
| 2024-12-24 | 10.04 |
| 2024-12-23 | 9.98 |
| 2024-12-20 | 9.89 |
| 2024-12-19 | 9.72 |
| 2024-12-18 | 9.68 |
| 2024-12-17 | 9.91 |
| 2024-12-16 | 9.83 |
| 2024-12-13 | 9.81 |
| 2024-12-12 | 9.86 |
| 2024-12-11 | 9.86 |
| 2024-12-10 | 9.86 |
| 2024-12-09 | 9.66 |
| 2024-12-06 | 9.84 |
| 2024-12-05 | 9.98 |
| 2024-12-04 | 9.78 |
| 2024-12-03 | 9.88 |
| 2024-12-02 | 10.05 |
| 2024-11-29 | 9.89 |
| 2024-11-27 | 9.87 |
| 2024-11-26 | 9.75 |
| 2024-11-25 | 9.65 |
| 2024-11-22 | 9.62 |
| 2024-11-21 | 9.57 |
| 2024-11-20 | 9.45 |
| 2024-11-19 | 9.35 |
| 2024-11-18 | 9.43 |
| 2024-11-15 | 9.42 |
| 2024-11-14 | 9.83 |
| 2024-11-13 | 9.89 |
| 2024-11-12 | 10.08 |
| 2024-11-11 | 10.38 |
| 2024-11-08 | 10.33 |
| 2024-11-07 | 10.48 |
| 2024-11-06 | 9.79 |
| 2024-11-05 | 9.62 |